文献速递消化道肿瘤放疗放疗物理与技术

可生物降解水凝胶间隔物用于胰腺癌放疗中十二指肠保护剂量预测模型

Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-07-19

本研究基于232例不可切除胰腺癌患者(33 Gy/5次)的立体定向体部放疗计划,建立重叠体积直方图(OVH)预测模型,用于筛选可能从水凝胶置入获益的患者并预测达到临床剂量约束所需的水凝胶厚度。线性回归显示Lx与Dx显著相关(r²=0.51,P<.01),OVH阈值Lˆ3cc=7 mm、Lˆ9cc=13 mm,在2例尸体标本和6例既往接受治疗的局部晚期胰腺癌患者模拟间隔物的CT扫描中验证,观察剂量均在预测范围内。

要点

  • OVH模型可预测哪些患者在水凝胶置入后能达到预设剂量约束。
  • L3cc-D3cc和L9cc-D9cc线性回归r²均为0.51(P<.01),OVH阈值Lˆ3cc=7 mm、Lˆ9cc=13 mm。
  • 尸体标本和模拟间隔物患者的计划剂量均在OVH模型预测范围内。

核心结论

  • 该模型可能预测哪些患者在立体定向体部放疗前需要置入水凝胶间隔物以满足预设剂量约束。
  • 通过预测所需目标水凝胶厚度,可更好地指导间隔物注射以提高疗效。

研究设计与样本

  • 基于232例不可切除胰腺癌患者(33 Gy/5次)立体定向体部放疗计划的剂量学分析,建立线性回归预测模型。
  • 使用2例尸体标本和6例既往接受治疗的局部晚期胰腺癌患者(模拟间隔物)的注水凝胶前后CT扫描治疗计划验证模型准确性。

主要发现

  • 线性回归分析显示Lx与Dx显著相关,L3cc-D3cc和L9cc-D9cc的r²均为0.51(均P<.01)。
  • OVH阈值Lˆ3cc=7 mm,Lˆ9cc=13 mm。
  • 尸体标本和模拟间隔物临床患者注水凝胶前后CT扫描的十二指肠观察计划剂量D3cc和D9cc均在OVH模型预测范围内。

关键数值与推荐

  • OVH指标L9cc和L3cc分别定义为十二指肠与肿瘤重叠体积为9 cm³和3 cm³时的肿瘤体积外扩距离。
  • D9cc和D3cc分别定义为十二指肠的剂量体积直方图中9 cm³和3 cm³体积对应的剂量。
  • 预测模型通过Lx与Dx之间的线性回归建立,其中x=3 cm³和9 cm³。
  • 预测目标间隔物厚度的OVH阈值为Lˆ3cc=7 mm和Lˆ9cc=13 mm。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We previously have shown the feasibility of duodenum sparing using a biodegradable hydrogel spacer in pancreatic cancer radiation therapy. In this study, we propose an overlap volume histogram (OVH) prediction model to select patients who might benefit from hydrogel placement and to predict the hydrogel spacing required to achieve clinical constraints. METHODS AND MATERIALS: OVH metrics for the duodenum were collected from the stereotactic body radiation therapy plans of 232 patients with unresectable pancreatic cancer (33 Gy in 5 fractions). OVH metrics L9cc and L3cc were defined as the tumor volume expansion distance at which 9 cm3 and 3 cm3 volumes of the duodenum overlap with tumor. D9cc and D3cc of the duodenum were defined as the dose-volume histogram dose to 9 cm3 and 3 cm3, respectively, of the duodenum. Prediction models were established by linear regression between Lx and Dx, where x = 3 cm3 and 9 cm3. OVH thresholds were obtained for predicting the target spacer thickness. The accuracy of the prediction model was then evaluated using treatment plans on pre-and post-hydrogel injection computed tomography scans from 2 cadaver specimens and 6 patients with previously treated locally advanced pancreatic cancer with simulated spacer. RESULTS: Linear regression analysis showed a significant correlation between Lx and Dx (r2 = 0.51 and 0.51 for L3cc-D3cc and L9cc-D9cc, respectively; both P < .01). The OVH thresholds were Lˆ3cc = 7 mm and Lˆ9cc = 13 mm. The observed planning doses D3cc and D9cc of duodenum from pre-and post-hydrogel injection computed tomography scans of cadaver specimens and clinical patients with simulated spacer using predicted target spacer thickness were within the OVH model prediction range. CONCLUSION: Our model may predict which patients require placement of a hydrogel spacer before stereotactic body radiation therapy to meet predefined dose constraints. Furthermore, by predicting the required target hydrogel thickness, the spacer injection can be better guided to improve efficacy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Feng Z, Rao AD, Cheng Z, et al. Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018. PMID: 30031143. doi:10.1016/j.ijrobp.2018.07.184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。